Related Experiment Video
Updated: May 14, 2026
08:17
Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016
[Peritoneal carcinomatosis of unknown origin]
N Marchal1, C Gennigens, G Jerusalem
1Université de Liège, Belgique.
Revue Medicale De Liege
|January 26, 2013
Summary
Peritoneal carcinomatosis, a secondary spread of cancer to the peritoneum, presents diagnostic and treatment challenges. A multidisciplinary approach is crucial, especially for women with carcinoma of unknown primary (CUP) who have a better prognosis.
Area of Science:
- Oncology
- Gastroenterology
- Surgical Oncology
Background:
- Peritoneal carcinomatosis involves secondary neoplastic invasion of the peritoneum.
- It poses significant challenges in diagnosis, origin investigation, and treatment.
- Carcinoma of unknown primary (CUP) with peritoneal spread requires specific management.
Observation:
- This clinical history highlights the complexities of managing peritoneal carcinomatosis.
- It underscores the critical need for a multidisciplinary team approach.
- The case illustrates difficulties in diagnosis and treatment planning.
Findings:
- Peritoneal carcinomatosis originating from an unknown primary tumor is classified as CUP.
- Women with peritoneal carcinomatosis often experience a more favorable outcome.
- Specific first-line treatments are recommended for this patient group.
Implications:
- Early and accurate diagnosis of peritoneal carcinomatosis is essential.
- Multidisciplinary collaboration improves patient outcomes.
- Tailored treatment strategies are vital for improving survival in peritoneal carcinomatosis, particularly in women.
